Results 101 to 110 of about 32,413 (228)
Pertussis vaccination in newborns
Expert Review of Vaccines, 2009 Bordetella pertussis remains in fifth place among the leading etiologies of vaccine-preventable deaths in children around the world. The impact of this disease is considerable in North America, Latin America, Europe and other parts of the world. Therefore, new vaccination strategies have been recommended in the last decade, predominantly to protect ...
openaire +2 more sources
The IgG response following infant diphtheria-tetanus-acellular pertussis (DTaP) immunization is influenced by the formulation of the infant and/or the adult vaccine (Tdap) given during pregnancy.
Halperin, Scott A. +5 more
core +1 more source
, 2014 OBJECTIVES To assess the effectiveness of three, four and five doses of acellular pertussis vaccine against pertussis notification for children aged 1 - < 4 years and 5 - < 12 years, and the effectiveness of three doses of acellular pertussis vaccine ...
Ware, Robert S. +16 more
core +1 more source
Pertussis Vaccination and Pregnancy [PDF]
Clinical Infectious Diseases, 2013 Leuridan, E. +3 more
openaire +3 more sources
Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
, 2009 The lack of a clear correlation between the levels of antibody to pertussis antigens and protection against disease lends credence to the possibility that cell-mediated immunity provides primary protection against disease.
I. Raw +32 more
core +1 more source
Protection against pertussis with a monocomponent pertussis toxoid vaccine
, 1997 This study was undertaken to assess the safety and protective efficacy against pertussis of a monocomponent pertussis toxoid vaccine in a society with hyperendemic pertussis.
Trollfors, Birger +3 more
core +1 more source
Evaluation of acellular pertussis vaccine: comparisons among different strains of mice. [PDF]
Emerg Microbes Infect, 2023 Wei J +8 more
europepmc +1 more source